Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patientsErika Morsia, Naseema Gangat, William J. Hogan et al.|American Journal of Hematology|2020Cited by 136
Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapyCharalampos Charalampous, Shaji Kumar, Utkarsh Goel et al.|Blood Advances|2023Cited by 16
Solitary plasmacytoma: single-institution experience, and systematic review and meta-analysis of clinical outcomesCharalampos Charalampous, Shaji Kumar, Jean‐Sébastien Claveau et al.|Blood Advances|2025Cited by 10
Abstract 3455: Prevalence of monoclonal gammopathy of undetermined significance (MGUS) in a Western Nigerian populationCeline M. Vachon, Solomon O. Rotimi, Cristine Allmer et al.|Cancer Research|2024Cited by 1